These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7594237)

  • 1. The effects of spironolactone on testosterone fractions and sex-hormone binding globulin binding capacity in hirsute women.
    Marcondes JA; Minanni SL; Luthold WW; Lerário AC; Nery M; Mendonça BB; Wajchenberg BL; Kirschner MA
    J Endocrinol Invest; 1995 Jun; 18(6):431-5. PubMed ID: 7594237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of the calculation of non-sex hormone-binding globulin-bound estradiol from total testosterone, total estradiol and sex hormone-binding globulin concentrations in human serum.
    Belgorosky A; Escobar ME; Rivarola MA
    J Steroid Biochem; 1987 Oct; 28(4):429-32. PubMed ID: 3669662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hirsutism in women with flutamide.
    Marcondes JA; Minnani SL; Luthold WW; Wajchenberg BL; Samojlik E; Kirschner MA
    Fertil Steril; 1992 Mar; 57(3):543-7. PubMed ID: 1531466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-sex hormone-binding globulin-bound testosterone as a marker for hyperandrogenism.
    Cumming DC; Wall SR
    J Clin Endocrinol Metab; 1985 Nov; 61(5):873-6. PubMed ID: 4044776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free testosterone and testosterone/SHBG index in hirsute women: a comparison of diagnostic accuracy.
    Carlström K; Gershagen S; Rannevik G
    Gynecol Obstet Invest; 1987; 24(4):256-61. PubMed ID: 2962909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the distribution of testosterone and estradiol serum fractions in hirsute women after administration of L-thyroxine.
    Belgorosky A; Kaplan J; Cardoso E; Hoschoian JC; Rivarola MA
    Medicina (B Aires); 1989; 49(4):331-5. PubMed ID: 2487742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.
    Diri H; Karaburgu S; Acmaz B; Unluhizarci K; Tanriverdi F; Karaca Z; Kelestimur F
    Gynecol Endocrinol; 2016; 32(1):42-5. PubMed ID: 26370923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of obesity on hormonal parameters in hirsute and nonhirsute women.
    Bernasconi D; Del Monte P; Meozzi M; Randazzo M; Marugo A; Badaracco B; Marugo M
    Metabolism; 1996 Jan; 45(1):72-5. PubMed ID: 8544780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism.
    Tiitinen A; Simberg N; Stenman UH; Ylikorkala O
    J Clin Endocrinol Metab; 1994 Aug; 79(2):447-51. PubMed ID: 8045961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of sex hormone binding globulin and free androgen index in the estimation of androgenic cases].
    Qiao FY; Lauritzen C
    J Tongji Med Univ; 1990; 10(2):124-8. PubMed ID: 2145442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel use of spironolactone: treatment of hirsutism.
    Shapiro G; Evron S
    J Clin Endocrinol Metab; 1980 Sep; 51(3):429-32. PubMed ID: 7410528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity regulates bioavailable testosterone levels in women with or without polycystic ovary syndrome.
    Penttilä TL; Koskinen P; Penttilä TA; Anttila L; Irjala K
    Fertil Steril; 1999 Mar; 71(3):457-61. PubMed ID: 10065782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The grade of hirsutism correlated to serum androgen levels and hormonal indices.
    Ruutiainen K; Erkkola R; Kaihola HL; Santti R; Irjala K
    Acta Obstet Gynecol Scand; 1985; 64(8):629-33. PubMed ID: 2938400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hirsutism with combined pill containing drospirenone.
    Gregoriou O; Papadias K; Konidaris S; Bakalianou K; Salakos N; Vrachnis N; Creatsas G
    Gynecol Endocrinol; 2008 Apr; 24(4):220-3. PubMed ID: 18382909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma sex hormone-binding globulin and androgen levels in the management of hirsute patients.
    Cunningham SK; Loughlin T; Culliton M; McKenna TJ
    Acta Endocrinol (Copenh); 1983 Nov; 104(3):365-71. PubMed ID: 6685420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone in combination drug therapy for unresponsive hirsutism.
    Pittaway DE; Maxson WS; Wentz AC
    Fertil Steril; 1985 Jun; 43(6):878-82. PubMed ID: 3158552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of albumin-bound testosterone.
    Manni A; Pardridge WM; Cefalu W; Nisula BC; Bardin CW; Santner SJ; Santen RJ
    J Clin Endocrinol Metab; 1985 Oct; 61(4):705-10. PubMed ID: 4040924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term treatment of hirsutism related to micropolycystic ovary syndrome with a combination type oral contraceptive containing desogestrel.
    Sobbrio GA; Granata A; D'Arrigo F; Arena D; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1989; 20(1):35-7. PubMed ID: 2528880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.